JW Medical Systems

EXCEL -The new generation product from JW Medical Systems is a coronary drug eluting stent using biodegradable PLA polymer as a drug carrier with Sirolimus. Sirolimus can inhibit vessel smooth muscle cell proliferation and the biodegradable polymer can be degraded into CO₂ & H₂O.

The first Drug-eluting stent with biodegradable polymer in China market

The stent has been clinically tested and proven by evidence-based medical studies through five-year clinical practice

The stent has been confirmed effectiveness and safety by JACC, the internationally authoritative scientific publication.

The evidence-based medical study of the stent has been released on TCT, the internationally authoritative scientific conference.

The outstanding features of EXCEL drug-eluting stent from JW Medical Systems include its long term efficacy, safety and cost effectiveness.

Long term efficacy – EXCEL has been applied in more than several hundred thousand cases in the past five years. The long term efficacy has been confirmed by authorized hospitals.

Safety: The drug is eluting gradually during a 6-months period following the stent implantation into the human body. The polymer coating can be degraded thoroughly into CO₂ & H₂O. The drug has no residual in the vessels whereas is more environmentally friendly and healthier.  It also prevents late stent thrombosis.

Efficiency & cost effectiveness:  Single side polymer coating technology is an advanced technology that only carry drug at the side of stent close to the vessel.  The drug can be eluted directly into the vessel wall which can increase the drug efficiency.  This is one unique and efficient way to reduce the binary restenosis and prevent stent thrombosis. According to numerical data from clinical practice there is no statistical difference between the group that used the anti-platelet therapy drug during the 6-months period post-implantation and the group that did not use the drug.  Theoretically, the selection of EXCEL implantation can save thousands of Yuan on the drug, can reduce long-term drug side effects, and can also reduce government spending on health resources.

Mature biodegradable coating technology, safe and environment-friendly

•First drug eluting stent using biodegradable polymer of lactic acid (PLA)

•Coating 100% degradable to CO₂ & H₂O

•Good biocompatibility

•Effective prevention of late/very late stent thrombosis

•Shorten time of dual anti-platelet therapy

•Hundreds of thousands of successful clinical cases of implanting

Bring you with adequate confidence in interventional therapy

Unique abluminal coating technology, economic and efficient

•Patent for abluminal coating technology

•Inhibiting endometrial hyperplasia and effectively reducing restenosis

•Avoiding delay of stent endothelialization and promoting immediate union of vascular walls

•Effective prevention of late/very late stent thrombosis

Release you from any future worry about interventional therapy

Exquisite stent structure design, easy of use

•Unique 6, 9 and open-cycle structure, with ultra-large side opening, more suitable to bifurcation

•Stent delivery system exquisitely and strongly designed, with hydrophilic coating for easy lubricating

•Stable stainless steel, demonstrating excellence for easy positioning

Provide you immediate advantageous experience in interventional therapy

Product performance

The product, via human femoral artery or radial artery, using the relevant interventional therapeutic tool, is mainly used for implanting into the location of human coronary artery with stenosis to support the vascular walls. Drug coated on stent is utilized to stop hyperplasia of vascular smooth muscle cell and prevent restenosis.